Request for approval of a Public Health or Safety Exemption from the competitive bid requirements with Merck & Co., Inc. d/b/a Merck Sharp & Dohme LLC; GlaxoSmithKline Holdings (Americas) Inc. d/b/a GlaxoSmithKline LLC; and Sanofi Vaccines US Inc. in the amount of $1,600,000 for various vaccines for the Refugee Health Screening Program for Public Health Services for the period of October 1, 2026 - September 30, 2027 using grant funds provided by the U.S. Department of Health and Human Services Refugee Medical Assistance Program. | Community Exchange
PolicyCountyOur Health
Request for approval of a Public Health or Safety Exemption from the competitive bid requirements with Merck & Co., Inc. d/b/a Merck Sharp & Dohme LLC; GlaxoSmithKline Holdings (Americas) Inc. d/b/a GlaxoSmithKline LLC; and Sanofi Vaccines US Inc. in the amount of $1,600,000 for various vaccines for the Refugee Health Screening Program for Public Health Services for the period of October 1, 2026 - September 30, 2027 using grant funds provided by the U.S. Department of Health and Human Services Refugee Medical Assistance Program.
Harris County seeks approval to buy up to $1.6 million in vaccines for its Refugee Health Screening Program using federal grant funds.
Harris County Commissioners Court is reviewing a request to spend up to $1,600,000 on vaccines from three suppliers — Merck, GlaxoSmithKline, and Sanofi — for the Refugee Health Screening Program. The vaccines would be purchased without a competitive bid under a public health or safety exemption. Funding comes from a U.S. Department of Health and Human Services grant and covers October 1, 2026 through September 30, 2027.
Harris County plans to spend up to $1,600,000 on vaccines for refugees without a standard competitive bid. Commissioners Court must approve the exemption. County residents may want to know how public health grant funds are spent.
